Editorial
doi: 10.1002/hep.25894.
Adeno-associated virus gene therapy prevents hepatocellular adenoma in murine model of glycogen storage disease type Ia
- PMID: 22706804
- DOI: 10.1002/hep.25894
Item in Clipboard
Editorial
Adeno-associated virus gene therapy prevents hepatocellular adenoma in murine model of glycogen storage disease type Ia
Hepatology.
2012 Nov.
No abstract available
Comment on
-
Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.Hepatology. 2012 Nov;56(5):1719-29. doi: 10.1002/hep.25717. Epub 2012 Aug 27. Hepatology. 2012. PMID: 22422504 Free PMC article.
Similar articles
-
Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.Hepatology. 2012 Nov;56(5):1719-29. doi: 10.1002/hep.25717. Epub 2012 Aug 27. Hepatology. 2012. PMID: 22422504 Free PMC article.
-
Gene therapy prevents hepatic tumor initiation in murine glycogen storage disease type Ia at the tumor-developing stage.J Inherit Metab Dis. 2019 May;42(3):459-469. doi: 10.1002/jimd.12056. Epub 2019 Mar 6. J Inherit Metab Dis. 2019. PMID: 30637773 Free PMC article.
-
Emerging roles of autophagy in hepatic tumorigenesis and therapeutic strategies in glycogen storage disease type Ia: A review.J Inherit Metab Dis. 2021 Jan;44(1):118-128. doi: 10.1002/jimd.12267. Epub 2020 Jul 2. J Inherit Metab Dis. 2021. PMID: 32474930 Review.
-
Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors.Mol Genet Metab. 2017 Mar;120(3):229-234. doi: 10.1016/j.ymgme.2017.01.003. Epub 2017 Jan 10. Mol Genet Metab. 2017. PMID: 28096054 Free PMC article.
-
Challenges of Gene Therapy for the Treatment of Glycogen Storage Diseases Type I and Type III.Hum Gene Ther. 2019 Oct;30(10):1263-1273. doi: 10.1089/hum.2019.102. Epub 2019 Aug 27. Hum Gene Ther. 2019. PMID: 31319709 Review.
Cited by
-
Ifit1 Protects Against Lipopolysaccharide and D-galactosamine-Induced Fatal Hepatitis by Inhibiting Activation of the JNK Pathway.J Infect Dis. 2015 Nov 1;212(9):1509-20. doi: 10.1093/infdis/jiv221. J Infect Dis. 2015. PMID: 26459629 Free PMC article.
-
Glycogen storage disease type I: Genetic etiology, clinical manifestations, and conventional and gene therapies.Pediatr Discov. 2023;1(2):e3. doi: 10.1002/pdi3.3. Epub 2023 Jul 24. Pediatr Discov. 2023. PMID: 38370424 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical